JenaValve
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
4 Cromwell, Irvine, California, 92610, U...Phone Number
(949) 767-2110Website
www.jenavalve.comRevenue
$29.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About JenaValve
JenaValve is a medical device company. It offers native aortic valve leaflets. The company was formed in 1995 and is based in Irvine, California.Explore more
JenaValve Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is JenaValve your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once JenaValve has new funding data
Website visits: Recent activity has been detected on your website
Click to see if JenaValve had a recent Job posting/layoffs
Product Launch: Get notified when JenaValve launches new products
Congratulate Masked Content for being promoted to Masked Content at JenaValve
Check out if JenaValve is spiking on competitors!
Check if JenaValve has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on JenaValve recently announced quarterly report
JenaValve, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to JenaValve
Compare insights from companies similar to JenaValve, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
JenaValve is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
JenaValve is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about JenaValve.
JenaValve financials insights
Gather financial insights about JenaValve, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$14M
2010
Private Equity
$13.5M
Series B
$19M
2016
Private Equity
$10M
2017
Private Equity
$9.4M
2018
Debt
$4.9M
2020
Other Financing Round
$50M
2022
Series C
$162.5M
JenaValve Tech Stack
A closer look at the technologies used by JenaValve
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Hiring Plans
JenaValve has more open roles in Medical & Health than it has had at any time in the past 12 months. Areas of expertise include: Clinical Trial Management Systems, Clinical Trial Development, Nursing, Good Clinical Practices (GCP), Clinical Research, Clinical Medicine, and ICH Guidelines.
Hiring Plans
Person-Based
Person-Based
JenaValve News & Media
JenaValve Appoints Matt Bacso as Chief Financial Officer
IRVINE, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Matt Bacso, as Chief Financial Officer, effective June 8, 2026. Matt will lead the company’s financial organization and capital markets activities as JenaValve advances its U.S. commercial launch of the Trilogy System for high risk, symptomatic, severe aortic regurgitation (ssAR). His appointment furtheJenaValve Appoints Maria Jose Arana as Vice President of Quality and Compliance
IRVINE, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Maria Jose Arana as Vice President of Quality and Compliance. Maria Jose will lead the company’s quality assurance and compliance strategy, overseeing the implementation of critical quality and compliance systems as JenaValve expands its commercial operations and advances its clinical programs. Her appoJenaValve names Edward Sarnowski as CTO - Medical Buyer
JenaValve Technology, Inc. announced the appointment of Edward (Ed) Sarnowski as Chief Technology Officer. Ed will lead the company’s R&D organization and drive the next phase of innovation as JenaValve advances its transcatheter aortic valve programs following the recent U.S. FDA approval of the Trilogy THV System for symptomatic, severe aortic regurgitation (ssAR). Ed brings […]JenaValve Appoints Edward Sarnowski as Chief Technology Officer
IRVINE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Edward (Ed) Sarnowski as Chief Technology Officer. Ed will lead the company's R&D organization and drive the next phase of innovation as JenaValve advances its transcatheter aortic valve programs following the recent U.S. FDA approval of the Trilogy THV System for symptomatic, severe aortic regurgitation
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding JenaValve
Sign Up For FreeTo access detailed company insights
JenaValve is a medical device company. It offers native aortic valve leaflets. The company was formed in 1995 and is based in Irvine, California.... Read More
